Our Offerings
Formulation Technology Platforms:
Ophthalmic*:
Nasal*:
Multidose and Unit Dose Preserved and Preservative Free Solutions, Suspensions Dry Powder, In Situ Gelling and Gels
Inhalation*:
Pressurized Metered Dose Nasals (pMDN), Nebulized Resuples and Pressurized Metered Dose Inhalers (pMDI), Dry Powder Inhalers (DPI) and Nebulized Respules (Blow Fill Seal)
Complex Injectables*:
Multidose and Unit Dose Pre-Filled Syringes, LyphoIlised Powders, Solutions, Suspension, Micro Sphere, Particulate, In Situ Gelling and Gels for Subcutaneous and Intramuscular Sustained Release Injection
Oral Liquids:
Multidose, Unit Dose, Palatable (Taste Making), Immediate and Extended Release, Dry Powders for Solutions/Suspensions, Liquid Solutions, Liquid Suspensions, Emulsions, Nano-Emulsions
Topicals:
Semisolids, and Liquid Formulations
Oral Solids:
Immediate and Extended-Release Tablets, Soft & Hard Gelatin Capsules with expertise in Multiparticulates, and Solubility Enhancement thru Amorphous Solid Dispersion and Lipid -Based Formulation Development.

Medicated Chewing Gum:
Development of medicated chewing gum thru Tableted gum technology
*Include drug devicedevelopment support, device design, selection, development and optimization.

Problem Solving:
Particle size Analysis (size and morphology):
Analytical Development
Delivering comprehensive analytical solutions tailored to your needs.
Reverse Engineering:
Qualitative and Quantitative determination of individual components in reference formulation to determine concentration and/or form ducts.
Drug Substance and RLD Characterization:
Characterization of Drug Substance to find sameness with individualized characterization study to compare with RLD. RLD characterization with respect to design space for Drug Product Development.
Method Development & Validation:
Customizable analytical method development and validation tailored through Design of Experiments (DOE) and Quality by Design (QbD) processes that meet all compendial and regulatory requirements. as per specific requirements.
In Vitro Bioequivalence:
Stability Program Management:
Pharmacopeial Testing:
Stability Indicating Methods:
Clinical Operation
Clinical Strategy and Design:
Biostatistics and Data Management:
Clinical Operations Support:
Quality Assurance and Compliance:

Module 5 Technical writing:
Regulatory Affairs
Regulatory Strategy:
Submission Management:
Labelling Compliance:
US Agent Services:


R&D Quality Assurance
Regulatory Audit Support:
Facility & System Audits:
Vendor-Independent Audits:
Lifecycle Quality Implementation:
Intellectual Property Rights
Patent Landscape Analysis:
Patentability Assessment:
Freedom to Operate Analysis:
PIV Litigation:
PIV Certification:
IP Due Diligence:
Patent Filing and Prosecution:


Customized Project Management Support
Communication & Governance:
Resource Allocation:
Risk Management:
Tracking & Accountability:
Change Management:
Stakeholder Communication:
Portfolio Selection and Commercial Assessment
Portfolio Selection Services:
Product Positioning:
Life Cycle Management:
Complementary Product Options:
Commercial Assessment:
Therapeutic Knowledge:
Strategic Advice:
